For how long is brain tissue salvageable? Thrombolysis-based evidence.
暂无分享,去创建一个
[1] R. Higashida,et al. Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial , 1999 .
[2] M. Kaste,et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.
[3] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[4] M. Kaste,et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.
[5] T. Brott,et al. Improved Reliability of the NIH Stroke Scale Using Video Training , 1994, Stroke.
[6] L. Ryan,et al. The Analysis of Multiple Correlated Binary Outcomes: Application to Rodent Teratology Experiments , 1989 .
[7] H. Schouten,et al. Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.
[8] K Y Liang,et al. Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.
[9] R. Knill-Jones,et al. Observer variability in assessing impaired consciousness and coma. , 1978, Journal of neurology, neurosurgery, and psychiatry.
[10] Mahoney Fi,et al. FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 1965 .
[11] R. Higashida,et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. , 1998, Stroke.
[12] J. Olney,et al. Excitotoxic amino acids and neuropsychiatric disorders. , 1990, Annual review of pharmacology and toxicology.